User:Mary Mendoza/Notebook/CHEM572 Exp. Biological Chemistry II/2013/03/20

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
(Histogram)
(Histogram)
Line 13: Line 13:
* The aspirin trials did not show inhibition. A possible conclusion for the inconsistency was that the aspirin stock solution has deteriorated.
* The aspirin trials did not show inhibition. A possible conclusion for the inconsistency was that the aspirin stock solution has deteriorated.
* Kaempferol trials were started.
* Kaempferol trials were started.
 +
* After examining some of the data, it was concluded to adjust the 40 μM adenosine concentration to 25 μM.
<!-- ##### DO NOT edit below this line unless you know what you are doing. ##### -->
<!-- ##### DO NOT edit below this line unless you know what you are doing. ##### -->

Revision as of 13:13, 22 March 2013

Project name Main project page
Previous entry      Next entry

Histogram

  • It was decided to create a histogram for each inhibitor which includes the flavonoids and the non-nucleoside, acetylsalicylic acid analogs. Each inhibitor consisted of three trials.
  • From Sigma, 500 μM Kaempferol (C15H10O6, MW 286.24 g/mol) stock solution was prepared in dimethylsulfoxide (DMSO).
  • A kinetic assay run of 40 μM adenosine without inhibitors was executed through the kinetics of the UVProbe system.
  • After the three trials of 40 μM adenosine, aspirin trials were conducted.
  • The aspirin trials did not show inhibition. A possible conclusion for the inconsistency was that the aspirin stock solution has deteriorated.
  • Kaempferol trials were started.
  • After examining some of the data, it was concluded to adjust the 40 μM adenosine concentration to 25 μM.


Personal tools